DRRX News and Press, DURECT Corporation

2024-05-21 10:10:08 ET More on DURECT DURECT Corporation (DRRX) Q1 2024 Earnings Call Transcript DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript DURECT Q1 2024 Earnings Preview DURECT and Charles River enter agreement for alzet in U.S., Canada ...

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...

2024-05-14 10:00:29 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Health...

A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...

2024-05-13 21:54:10 ET DURECT Corporation (DRRX) Q1 2024 Earnings Conference Call May 13, 2024 4:30 PM ET Company Participants Timothy M. Papp - CFO James E. Brown - CEO Conference Call Participants Francois Brisebois - Oppenheimer & Co. Carl Byrn...

2024-05-13 16:14:08 ET More on DURECT DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript DURECT Q1 2024 Earnings Preview DURECT and Charles River enter agreement for alzet in U.S., Canada Seeking Alpha’s Quant Rating on DURECT Historica...

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis -         Webcast of Ea...

Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update PR Newswire CUPERTINO, Calif. , May 7, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development...

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis PR Newswire CUPERTINO, Calif. , April 30, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage b...